文献速递临床免疫临床微生物

单一定量酶免疫法检测血清中组织胞浆菌和芽生菌抗原

Detection of Histoplasma capsulatum and Blastomyces dermatitidis antigens in serum using a single quantitative enzyme immunoassay.
PubMed 文献 · J Clin Microbiol · 2023-12-15

该研究回顾性分析3,529例同一血清样本的组织胞浆菌和芽生菌抗原检测,两种检测总体一致率为99.3%(kappa 0.859)。评估Gotham BioTech芽生菌抗原EIA与MiraVista芽生菌EIA的阳性、阴性和总体一致率均为100%(24/24、57/57、81/81);与MiraVista组织胞浆菌EIA的阳性、阴性和总体一致率分别为91.3%(63/69)、98%(100/102)、95.3%(163/171)。提示单一抗原检测法可优化检测利用并降低患者成本。

要点

  • 组织胞浆菌和芽生菌抗原EIA间交叉反应高,单一检测可覆盖两种抗原。
  • GBA EIA与MVB EIA的阳性、阴性和总体一致率均为100%。
  • GBA EIA与MVH EIA总体一致率95.3%,不一致样本中GBA结果多不准确。

核心结论

  • GBA EIA与常用的芽生菌和组织胞浆菌抗原EIA具有高度一致性,单一检测可优化检测利用并降低成本。

研究设计与样本

  • 回顾性分析3,529例同一血清样本的组织胞浆菌和芽生菌抗原检测结果,比较两种检测的一致性。
  • 评估Gotham BioTech芽生菌抗原EIA(GBA EIA)检测血清中芽生菌和组织胞浆菌抗原的性能。
  • GBA EIA与MiraVista芽生菌EIA(MVB EIA)比较使用81份血清,与MiraVista组织胞浆菌EIA(MVH EIA)比较使用171份血清。

主要发现

  • 3,529例同一血清样本中,组织胞浆菌和芽生菌抗原检测总体一致率为99.3%(3,506/3,529;kappa 0.859)。
  • GBA EIA与MVB EIA的阳性、阴性和总体一致率均为100%(24/24、57/57、81/81)。
  • GBA EIA与MVH EIA的阳性、阴性和总体一致率分别为91.3%(63/69)、98%(100/102)、95.3%(163/171)。
  • 8例GBA/MVH EIA结果不一致的患者中,7例进行了额外真菌检测,结果提示MVH和GBA结果分别有2例和5例不准确。

临床怎么用

  • 利用芽生菌和组织胞浆菌抗原EIA间的高交叉反应性,可考虑使用单一抗原检测法同时检测两种真菌抗原。
  • 单一检测法有助于优化检测利用、降低患者成本,并保持较高的诊断准确性。

局限性

  • 本研究为回顾性分析,部分比较基于有限样本量(如不一致结果仅8例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Histoplasma and Blastomyces antigen detection assays are commonly used diagnostic tools. However, a high level of cross-reactivity between these antigens prevents definitive pathogen identification by these assays alone. Retrospective analysis of 3,529 patients with Histoplasma and Blastomyces antigen testing performed on the same serum sample yielded an overall percent agreement of 99.3% (3,506 of 3,529; kappa: 0.859) between the two assays, suggesting that use of a single assay to detect both antigens may be an alternative diagnostic approach. We assessed performance of the Gotham BioTech Blastomyces antigen (GBA) enzyme immunoassay (EIA) (Portland, Maine) for detection of Blastomyces and Histoplasma antigens in serum. Comparison to the MiraVista Diagnostics Blastomyces (MVB) EIA showed 100% positive (24 of 24), negative (57 of 57), and overall (81 of 81) percent agreement. Additionally, 171 sera were used to compare the GBA EIA to the MiraVista Diagnostics Histoplasma (MVH) EIA, which showed 91.3% (63 of 69), 98% (100 of 102), and 95.3% (163 of 171) positive, negative, and overall percent agreement, respectively. Among eight patients with discordant GBA/MVH EIA results, seven had additional fungal testing performed, and results suggested that the MVH and GBA results were inaccurate for two and five samples, respectively. Overall, this study suggests that the GBA EIA has a high level of agreement with both of the commonly used, individual Blastomyces and Histoplasma antigen EIAs. By taking advantage of the high level of cross-reactivity between Blastomyces and Histoplasma antigen EIAs, utilization of a single antigen detection assay for these fungi provides an opportunity to optimize test utilization and decrease patient cost while maintaining a high level of diagnostic accuracy.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Granger D, Streck NT, Theel ES, et al. Detection of Histoplasma capsulatum and Blastomyces dermatitidis antigens in serum using a single quantitative enzyme immunoassay. J Clin Microbiol. 2023. PMID: 38099670. doi:10.1128/jcm.01213-23

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。